investing

Analysts Morgan Stanley upgraded Lockheed Martin (LMT) to overweight and raised target price to $835, expecting 38% upside

10/26/2026, 05:38 AM investing rating_growth Analysts: analysts, Morgan Stanley defense Lockheed Martin

Morgan Stanley's upgrade of Lockheed Martin to overweight, along with a raised price target, indicates strong potential for the company's stock following a significant defense contract with the U.S. government.

Apollo Global Management to Acquire Nearly 10% Stake in Mubadala Capital, Abu Dhabi’s Alternative Asset Manager

10/26/2026, 04:38 AM investing announcement Apollo Global Management

Apollo Global Management is set to acquire a nearly 10% stake in Mubadala Capital, enhancing its strategic presence in Abu Dhabi and reflecting a growing trend of American investment firms deepening ties in the Middle East.

Analysts Barclays upgraded Tesla (TSLA) to overweight and raised target price to $450, citing potential merger with SpaceX

10/26/2026, 04:38 AM investing rating_growth Analysts: analysts, Barclays auto SpaceX Tesla

Barclays has upgraded Tesla's stock rating to overweight, citing a potential merger with SpaceX as a key driver for future growth and a price target increase to $450, indicating a 21% upside.

Analysts Goldman Sachs and Citi assess SpaceX’s strategy to access 80,000 cell sites amid rising competition with major telecoms

10/25/2026, 05:31 AM investing review Analysts: analysts, Citi, Goldman Sachs telecom SpaceX T-Mobile US American Tower Crown Castle AT&T

SpaceX's discussions to access up to 80,000 cell sites could significantly impact the telecom market by increasing competition against established players like AT&T and T-Mobile. Analysts suggest this move aligns with SpaceX's strategy to enhance its wireless network capabilities and reduce reliance on partnerships.

Analysts Piper Sandler highlight the resurgence of biotech stocks driven by innovation and AI advancements

10/24/2026, 06:31 AM investing review Analysts: analysts, Piper Sandler biotech ai Twist Bioscience 10x Genomics Illumina Inc. Moderna Eli Lilly

Moderna's stock experienced a significant drop, yet it remains a leader in a thriving biotech sector that has seen substantial gains this year. The overall market is buoyed by promising clinical trial results and advancements in drug development technologies.

Analysts Goldman Sachs recommend buying top tech stocks including Microsoft (MSFT), Alphabet (GOOGL), and Zeta Global (ZETA) ahead of earnings

10/24/2026, 06:31 AM investing recommendation Analysts: analysts, Goldman Sachs software internet Microsoft Alphabet Zeta Global (ZETA)

Goldman Sachs identifies several tech stocks, including Microsoft, Alphabet, and Zeta Global, as having significant upside potential ahead of their upcoming earnings reports, driven by strong demand for AI and modernization trends in enterprise software.

Apple (AAPL) Poised to Reclaim Title as World’s Largest Company from Nvidia (NVDA) Ahead of Earnings Report

10/23/2026, 12:37 PM investing forecast software consumer Nvidia Apple

Apple is poised to reclaim its position as the world's largest company, surpassing Nvidia, driven by strong consumer demand for its new iPhone Duo and upcoming earnings expectations.

Analysts raised target price for Kinder Morgan (KMI) following record earnings and strong natural gas demand

10/23/2026, 11:37 AM investing rating_growth Analysts: analysts energy Williams Companies Energy Transfer Kinder Morgan

The decline in U.S. natural gas prices presents a favorable environment for midstream operators like Kinder Morgan, Energy Transfer, and Williams, which benefit from increased throughput and stable fee-based revenues despite the pressures on gas drillers.

S&P 500 Faces Bearish Chart Pattern Amidst Struggles to Break Above 7,800

10/23/2026, 09:38 AM investing research

The S&P 500 is currently facing challenges in breaking above the 7,800 level, raising concerns about a potential bearish trend similar to past market corrections. Investors should be cautious as repeated failures to sustain bullish patterns could lead to a significant decline.

Analysts recommend buying Cerebras Systems (CBRS) shares as stock price declines present a buying opportunity

10/23/2026, 07:38 AM investing recommendation Analysts: analysts ai semiconductors

Cerebras Systems, an AI chipmaker, has seen its stock drop significantly, presenting a potential buying opportunity for investors, according to Paul Meeks of Freedom Capital Markets. He believes the company's innovative technology and substantial customer contracts could lead to significant revenue growth despite current market concerns.